1. Home
  2. GOOD vs GALT Comparison

GOOD vs GALT Comparison

Compare GOOD & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Commercial Corporation Real Estate Investment Trust

GOOD

Gladstone Commercial Corporation Real Estate Investment Trust

N/A

Current Price

$9.76

Market Cap

478.5M

Sector

Real Estate

ML Signal

N/A

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$2.90

Market Cap

397.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOOD
GALT
Founded
2003
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.5M
397.3M
IPO Year
2003
2008

Fundamental Metrics

Financial Performance
Metric
GOOD
GALT
Price
$9.76
$2.90
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $12.88
N/A
AVG Volume (30 Days)
★ 695.4K
185.4K
Earning Date
11-03-2026
11-16-2026
Dividend Yield
★ 12.40%
N/A
EPS Growth
N/A
★ 36.84
EPS
★ 0.08
N/A
Revenue
★ $161,336,000.00
N/A
Revenue This Year
$5.86
N/A
Revenue Next Year
$1.99
N/A
P/E Ratio
$121.06
★ N/A
Revenue Growth
★ 8.00
N/A
52 Week Low
$9.54
$2.03
52 Week High
$13.28
$7.13

Technical Indicators

Market Signals
Indicator
GOOD
GALT
Relative Strength Index (RSI) 21.59 35.26
Support Level N/A $2.78
Resistance Level $13.07 $3.30
Average True Range (ATR) 0.34 0.30
MACD -0.07 -0.03
Stochastic Oscillator 9.90 5.13

Price Performance

Historical Comparison
GOOD
GALT

About GOOD Gladstone Commercial Corporation Real Estate Investment Trust

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: